Previous 10 | Next 10 |
CLEVELAND , Aug. 19, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with...
CLEVELAND , Aug. 15, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in two upcoming investor conferences in New York, NY . An audio webcast of the Company's presentations will be available on the events and webinars section of...
Thesis Correct, Shorts Win I initially wrote up VRAY as a short in July of 2017 ( here ). The short thesis has played out exactly as expected with the only surprise coming from how long it took for the short to work. VRAY bulls certainly put up a good fight over the last two years but it...
Gainers : Arcadia Biosciences (NASDAQ: RKDA ) +49% . Soliton (NASDAQ: SOLY ) +24% . GTT Communications (NYSE: GTT ) +17% . Everspin Technologies (NASDAQ: MRAM ) +16% . AMAG Pharmaceuticals (NASDAQ: AMAG ) +15% . China SXT Pharmaceuticals (NASDAQ: SXTC ) +15% . TrueCar (NASDAQ: T...
Arcadia Biosciences (NASDAQ: RKDA ) +34% . More news on: Arcadia Biosciences, Inc., ViewRay, Inc., Stocks on the move, Read more ...
Gainers: Arcadia Biosciences (NASDAQ: RKDA ) +123% . Two River Bancorp (NASDAQ: TRCB ) +46% . InnerWorkings (NASDAQ: INWK ) +45% . Cutera (NASDAQ: CUTR ) +30% . PCTEL (NASDAQ: PCTI ) +24% . iFresh (NASDAQ: IFMK ) +21% . Puma Biotechnology (NASDAQ: PBYI ) +20% . China Natural R...
Thinly traded nano cap ViewRay (NASDAQ: VRAY ) is down 52% premarket on increased volume following its Q2 report released after the close yesterday that included softer revenue guidance. Highlights: More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Earn...
ViewRay, Inc. (VRAY) Q2 2019 Earnings Conference Call August 08, 2019, 04:30 PM ET Company Participants Michaella Gallina - Head of IR Scott Drake - President and CEO Shar Matin - COO Jim Alecxih - Chief Commercial Officer Conference Call Participants Anthony Petrone - Je...
ViewRay (NASDAQ: VRAY ): Q2 GAAP EPS of -$0.32 misses by $0.08 . More news on: ViewRay, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CLEVELAND , Aug. 8, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2019 . Second Quarter 2019 Summary: The Company is updating 2019 guidance and now anticipates total revenue in the range of ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...